GSK
$43.13
Glaxosmithkline Plc
$.23
.54%
GSK
Earnings Whisper ®
N/A
3rd Quarter September 2016
Consensus:  $0.77
Revenue:  $10.45 Bil
Wednesday
Oct 26
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when GSK reports earnings?
Beat
Meet
Miss

Where is GSK's stock price going from here?
Up
Flat
Down
Stock chart of GSK
Analysts
Summary of analysts' recommendations for GSK
Score
Grade
Pivots
Resistance
$44.37
$44.02
$43.46

$43.11

Support
$42.55
$42.20
$41.64
Tweet
Growth
Description
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Peers
Johnson & JohnsonRegeneron PharmaceuticalsCelgeneBristol-Myers SquibbEndo International plcPerrigoEli LillyValeant Pharmaceuticals InternationalBioMarin PharmaceuticalVertex Pharmaceuticals